Supha Pharmachem (BOM:539561) EPS (Basic): ₹0.13 (TTM As of Sep. 2025)


BOM:539561 Supha Pharmachem Ltd BOM:539561
58 GF Score
Price ₹0.29
GF Value ₹1.53
Valuation Possible Value Trap
! 12 Warning Signs
View Full Analysis

What is Supha Pharmachem EPS (Basic)?

Supha Pharmachem BOM:539561 -3.33% 58 EPS (Basic) is ₹0.13 as of Sep. 2025. GuruFocus rates BOM:539561 with a GF Score™ of 58/100 and a GF Value™ of ₹1.53 (Possible Value Trap). The stock has 12 warning signs investors should review.

Supha Pharmachem's basic earnings per share (Basic EPS) for the three months ended in Sep. 2025 was ₹0.10. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2025 was ₹0.13.

Supha Pharmachem's EPS (Diluted) for the three months ended in Sep. 2025 was ₹0.10. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was ₹0.13.

Supha Pharmachem's EPS without NRI for the three months ended in Sep. 2025 was ₹0.10. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was 0.13.

During the past 12 months, Supha Pharmachem's average EPS without NRIGrowth Rate was -99.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 22.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 100.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Supha Pharmachem's highest 3-Year average EPS without NRI Growth Rate was 313.80% per year. The lowest was 22.60% per year. And the median was 183.60% per year.

Supha Pharmachem  (BOM:539561) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Supha Pharmachem EPS (Basic) Related Terms

Supha Pharmachem EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Supha Pharmachem's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supha Pharmachem EPS (Basic) Chart

Supha Pharmachem Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.09 0.57 0.04

Supha Pharmachem Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.01 -0.04 0.05 0.10
BOM:539561
58GF Score
Supha Pharmachem Ltd BOM:539561
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supha Pharmachem EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Supha Pharmachem's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(21.294-0)/577.654
=0.04

Supha Pharmachem's Basic EPS for the quarter that ended in Sep. 2025 is calculated as

Basic EPS (Q: Sep. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(86.234-0)/862.340
=0.10

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹0.13 mean?
Supha Pharmachem (BOM:539561) has a EPS (Basic) of ₹0.13 as of Sep. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Supha Pharmachem and its competitors.
Is Supha Pharmachem's EPS (Basic) too high?
Supha Pharmachem's current EPS (Basic) is ₹0.13. Overall, Supha Pharmachem has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Supha Pharmachem's EPS (Basic) compare to ZTS?
Supha Pharmachem's EPS (Basic) of ₹0.13 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Supha Pharmachem and its competitors. Supha Pharmachem's current EPS (Basic) is ₹0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supha Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Supha Pharmachem (BOM:539561) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1.53, compared to a current price of ₹0.29 — trading 81% below its estimated fair value. The current EPS (Basic) is ₹0.13. Supha Pharmachem's overall GF Score™ is 58/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Supha Pharmachem (BOM:539561), the current EPS (Basic) is ₹0.13 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supha Pharmachem (BOM:539561) Overvalued in 2026?

Based on GuruFocus' analysis, Supha Pharmachem stock appears to be undervalued. The current stock price of ₹0.29 is trading 81% below its estimated GF Value™ of ₹1.53. GuruFocus considers Supha Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:539561:

  • EPS (Basic): ₹0.13
  • GF Value™: ₹1.53 vs. price of ₹0.29 (81% below fair value)
  • GF Score™: 58/100 with 12 warning signs

No single metric tells the full story. See the BOM:539561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Supha Pharmachem Business Description

Address Saugbaug Road, Office No. 9, Behind Ravi Vihar Hotel, K Raheja Prime, Marol Industrial Estate, Andheri (East), Mumbai, MH, IND, 400059
Supha Pharmachem Ltd, formerly known as Remedium Lifecare Ltd, is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).
58GF Score

Get the complete analysis for BOM:539561

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.29
Price
₹1.53
GF Value